Skip to main content

Table 3 Multivariate survival analyses for the patients with SSC of ovary in the SEER database (2004–2016, N = 180)

From: Poorer prognosis of ovarian squamous cell carcinoma than serous carcinoma: a propensity score matching analysis based on the SEER database

 

Overall survival

Cause-specific survival

Variables

HR

95%CI

P-value

HR

95%CI

P-value

Age

 ≤67

1

  

1

  

 > 67

6.77

2.55–18.01

< 0.001

6.39

1.84–22.25

0.004

Tumor size (mm)

 < 50

1

  

1

  

 50–150

5.17

1.14–23.49

0.033

7.07

0.81–61.35

0.076

 > 150

7.98

1.47–43.42

0.016

12.00

1.21–119.19

0.034

Laterality

 Unilateral

1

  

1

  

 Bilateral

4.01

1.03–15.56

0.045

3.76

0.73–19.38

0.113

FIGO stage

 I

1

  

1

  

 II

1.15

0.25–5.25

0.855

0.82

0.14–4.79

0.823

 III

2.86

0.82–9.92

0.099

1.83

0.43–7.91

0.416

 IV

8.73

2.50–30.46

0.001

9.17

2.32–36.26

0.002

  1. Variables in Cox regression models included: serum CA125, grade, surgery, lymphadenectomy, radiotherapy, and chemotherapy
  2. Abbreviations: SCC Squamous cell carcinoma; SEER Surveillance Epidemiology and End Results Program; FIGO International Federation of Gynecology and Obstetrics